<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The authors report the case of a young woman aged 29, mother of 2 children, presenting a <z:e sem="disease" ids="C0032807" disease_type="Disease or Syndrome" abbrv="">post-phlebitic syndrome</z:e> with hyperalgic capillaritic <z:mpath ids='MPATH_579'>ulcer</z:mpath>, a 10 year history of serious thrombophlebitic episodes with repeated <z:hpo ids='HP_0002204'>pulmonary embolism</z:hpo> despite <z:chebi fb="5" ids="28304">heparin</z:chebi> therapy, and reports of similar episodes in the family, some of which proved fatal </plain></SENT>
<SENT sid="1" pm="."><plain>Haematological study showed a clear diminution in progressive antithrombin activity </plain></SENT>
<SENT sid="2" pm="."><plain>A discussion follows on the clinical and haematological aspects of this constitutional and familial deficiency, which has been known since 1965 (Egelberg) </plain></SENT>
<SENT sid="3" pm="."><plain>The relative rarity of this condition should not prevent the routine search (by combined functional, immunological and chromogenic estimation) in the presence of repeated <z:mp ids='MP_0005048'>thrombosis</z:mp>, and when the <z:mp ids='MP_0005048'>thrombosis</z:mp> is biologically resistant to <z:chebi fb="5" ids="28304">heparin</z:chebi> : in such cases, the indication for long term treatment with <z:chebi fb="6" ids="28384">vitamin K</z:chebi> <z:chebi fb="68" ids="48706">antagonists</z:chebi> is undeniable </plain></SENT>
</text></document>